René Riedel

René Riedel

Auto-generated profile, based on publicly available information

René Riedel

Deutsches Rheuma-Forschungszentrum Berlin

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2015 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JWJan P. Weber
Jan P. Weber
FFFranziska Fuhrmann
Franziska Fuhrmann
RFRandi K. Feist
Randi K. Feist
ALAnnette Lahmann
Annette Lahmann
MBMaysun S. Al Baz
Maysun S. Al Baz
AHAndreas Hutloff
Andreas Hutloff
The co-stimulators ICOS (inducible T cell co-stimulator) and CD28 are both important for T follicular helper (TFH) cells, yet their individual contributions are unclear. Here, we show that each molecule plays an exclusive role at different stages of TFH cell development. While CD28 regulated early expression of the master transcription factor Bcl-6, ICOS co-stimulation was essential to maintain the phenotype by regulating the novel TFH transcription factor Klf2 via Foxo1. Klf2 directly binds to Cxcr5, Ccr7, Psgl-1, and S1pr1, and low levels of Klf2 were essential to maintain this typical TFH homing receptor pattern. Blocking ICOS resulted in relocation of fully developed TFH cells back to the T cell zone and reversion of their phenotype to non-TFH effector cells, which ultimately resulted in breakdown of the germinal center response. Our study describes for the first time the exclusive role of ICOS and its downstream signaling in the maintenance of TFH cells by controlling their anatomical localization in the B cell follicle.

10 October 2010 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
ASAnna-Barbara Stittrich
Anna-Barbara Stittrich
CHClaudia Haftmann
Claudia Haftmann
ESEvridiki Sgouroudis
Evridiki Sgouroudis
AKAnja Andrea Kühl
Anja Andrea Kühl
AHAhmed Nabil Hegazy
Ahmed Nabil Hegazy
MMMir-Farzin Mashreghi
Mir-Farzin Mashreghi

18 June 2014 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
RNRebecca Noster
Rebecca Noster
RRRené Riedel
René Riedel
MMMir-Farzin Mashreghi
Mir-Farzin Mashreghi
HRHelena Radbruch
Helena Radbruch
LHLutz Harms
Lutz Harms
Christina ZielinskiChristina Zielinski
Christina Zielinski
GM-CSF–producing T helper cells in humans follow a distinct regulation program as compared to T H 17 cells and are associated with multiple sclerosis.

1 May 2017 in Cell Reports
Verified
Journal Article
Open access
VGVictor Greiff
Victor Greiff
UMUlrike Menzel
Ulrike Menzel
EMEnkelejda Miho
Enkelejda Miho
CWCédric Weber
Cédric Weber
RRRené Riedel
René Riedel
SRSai T. Reddy
Sai T. Reddy
Antibody repertoire diversity and plasticity is crucial for broad protective immunity. Repertoires change in size and diversity across multiple B cell developmental stages and in response to antigen exposure. However, we still lack fundamental quantitative understanding of the extent to which repertoire diversity is predetermined. Therefore, we implemented a systems immunology framework for quantifying repertoire predetermination on three distinct levels: (1) B cell development (pre-B cell, naive B cell, plasma cell), (2) antigen exposure (three structurally different proteins), and (3) four antibody repertoire components (V-gene usage, clonal expansion, clonal diversity, repertoire size) extracted from antibody repertoire sequencing data (400 million reads). Across all three levels, we detected a dynamic balance of high genetic (e.g., >90% for V-gene usage and clonal expansion in naive B cells) and antigen-driven (e.g., 40% for clonal diversity in plasma cells) predetermination and stochastic variation. Our study has implications for the prediction and manipulation of humoral immunity.

1 January 2016 in Mucosal Immunology
Verified
Journal Article
Open access
PDF file
ALA Lemke
A Lemke
MKM Kraft
M Kraft
KRK Roth
K Roth
RRR Riedel
R Riedel
DLD Lammerding
D Lammerding
AHAnja Erika Hauser
Anja Erika Hauser
During systemic immune responses, plasma blasts are generated in secondary lymphoid organs and migrate to the bone marrow, where they can become long-lived, being responsible for the maintenance of long-term antibody titers. Plasma blasts generated in mucosal immune responses of the small intestine home to the lamina propria (LP), producing mainly immunoglobulin A. The migration of these antibody-secreting cells is well characterized during acute immune responses. Less is known about their lifetime and contribution to the long-lived bone marrow compartment. Here we investigate the lifetime of plasma cells (PCs) and the relationship between the PC compartments of the gut and bone marrow after oral immunization. Our findings indicate that PCs in the LP can survive for extended time periods. PCs specific for orally administered antigens can be detected in the bone marrow for at least 9 months after immunization, indicating that the mucosal PC compartment can contribute to the long-lived PC pool in this organ, independent of the participation of splenic B cells. Our findings suggest that the compartmentalization between mucosal and systemic PC pools is less strict than previously thought. This may have implications for the development of vaccines as well as for autoantibody-mediated diseases.

31 January 2015 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
ÖAÖzen Sercan Alp
Özen Sercan Alp
SDSibel Durlanik
Sibel Durlanik
DSDaniel Schulz
Daniel Schulz
MMMairi McGrath
Mairi McGrath
JGJoachim R. Grün
Joachim R. Grün
ARAndreas Radbruch
Andreas Radbruch
It is believed that memory CD8+ T cells are maintained in secondary lymphoid tissues, peripheral tissues, and BM by homeostatic proliferation. Their survival has been shown to be dependent on IL‐7, but it is unclear where they acquire it. Here we show that in murine BM, memory CD8+ T cells individually colocalize with IL‐7+ reticular stromal cells. The T cells are resting in terms of global transcription and do not express markers of activation, for example, 4‐1BB (CD137), IL‐2, or IFN‐γ, despite the expression of CD69 on about 30% of the cells. Ninety‐five percent of the memory CD8+ T cells in BM are in G0 phase of cell cycle and do not express Ki‐67. Less than 1% is in S/M/G2 of cell cycle, according to propidium iodide staining. While previous publications have estimated the extent of proliferation of CD8+ memory T cells on the basis of BrdU incorporation, we show here that BrdU itself induces proliferation of CD8+ memory T cells. Taken together, the present results suggest that CD8+ memory T cells are maintained as resting cells in the BM in dedicated niches with their survival conditional on IL‐7 receptor signaling.